PHILADELPHIA, Feb. 15, 2019 /PRNewswire-PRWeb/ -- ControlRad, LLC, a privately-held medical technology company, focused on dramatically reducing the amount of radiation exposure during fluoroscopically guided procedures, is pleased to announce that Chris Fair has joined its senior management team as Executive Vice President and President of the Mobile C-arm business.
Mr. Fair has been a leader in the musculoskeletal and regenerative marketplace for over 25 years including taking part in several successful exits. Most recently, Mr. Fair was the Chief Executive Officer of Spinal Elements, a Kohlberg & Company operating company focused in the spinal implant marketplace.
"Chris is an outstanding addition to our team," says Guillaume Bailliard, ControlRad CEO. "As we move into an accelerated growth mode, Chris' background in building successful medical device companies will be a major asset. Chris will be responsible for building the mobile C-arm business, among other key corporate initiatives."
"I am honored to join Guillaume and his team to help build a rock-solid foundation for sustainable and scalable success. ControlRad is perfectly positioned to change the lives of thousands of patients and medical staff around the world. I am excited to have the opportunity to help make such a profound difference," says Mr. Fair. "In my career, I have seen a few technologies at an early stage that you know will significantly impact the health and safety of so many lives. ControlRad's platform does that as well as provides unparalleled protection to nurses and surgeons treating the patient."
Chris currently sits on the Parker H Petit Institute for Bioengineering and Bioscience Advisory Board of the Georgia Institute of Technology as well as several privately held medical and regenerative medicine technology companies. Mr. Fair graduated from the University of Richmond Robins School of Business.
About ControlRad
ControlRad is a privately held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided procedures (FGP) for patients and healthcare professionals. These products are designed to improve safety without compromising image quality or workflow. This is accomplished with an integrated set of proprietary components, which optimize the X-ray beam to deliver optimal image quality in the clinically-relevant region while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Philadelphia and has engineering development facilities in Kfar Saba, Israel. For more information, visit https://www.controlrad.com.
SOURCE ControlRad
Share this article